About
Silence Therapeutics is a biotechnology company developing RNA interference (RNAi) therapeutics using precision-engineered siRNAs to target and treat genetic and cardiometabolic diseases, advancing programs through preclinical and clinical development.
Explore Silence Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.